Pembrolizumab Combo Improves pCR Rate in Advanced Gastric/GEJ Cancer
Written by
Cancer Network
Published
0
comments
0
min
Data from KEYNOTE-585 showed that adding pembrolizumab to chemotherapy did not negatively impact health-related quality of life vs placebo/chemotherapy.